Author

Antonio Gasbarrini

POLIPROTECT VS OMEPRAZOLE IN THE RELIEF OF HEARTBURN, EPIGASTRIC PAIN AND BURNING IN NERD AND EPS PATIENTS: A RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, REFERENCE PRODUCT CONTROLLED, PARALLEL GROUP, NON-INFERIORITY CLINICAL STUDY
POLIPROTECT VS OMEPRAZOLE IN THE RELIEF OF HEARTBURN, EPIGASTRIC PAIN AND BURNING IN NERD AND EPS PATIENTS: A RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, REFERENCE PRODUCT CONTROLLED, PARALLEL GROUP, NON-INFERIORITY CLINICAL STUDY

Antonio Gasbarrini  et al.

REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY
REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY

Antonio Gasbarrini  et al.

IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER
IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER

Antonio Gasbarrini  et al.

IPMN PROGRESSION OVER TIME: THE ROLE OF LIFESTYLE AND MEDICATIONS
IPMN PROGRESSION OVER TIME: THE ROLE OF LIFESTYLE AND MEDICATIONS

Antonio Gasbarrini  et al.

LONG TERM FOLLOW-UP OF CHRONIC LIVER DISEASE IN WILSON PATIENTS: THE ROLE OF NON INVASIVE TESTS
LONG TERM FOLLOW-UP OF CHRONIC LIVER DISEASE IN WILSON PATIENTS: THE ROLE OF NON INVASIVE TESTS

Antonio Gasbarrini  et al.

EARLY METABOLIC EVALUATION OF RESPONSE BY 13N-AMMONIA PET-CT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH ANTIANGIOGENIC THERAPY
EARLY METABOLIC EVALUATION OF RESPONSE BY 13N-AMMONIA PET-CT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH ANTIANGIOGENIC THERAPY

Antonio Gasbarrini  et al.

HISTOLOGICAL FEATURES OF JOINT INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PERIPHERAL ARTHRITIS
HISTOLOGICAL FEATURES OF JOINT INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PERIPHERAL ARTHRITIS

Antonio Gasbarrini  et al.

IL-33/ST2 AND GUT MICROBIOTA AXIS CAN MODULATE THE INFLAMMATORY PROCESS OF ULCERATIVE COLITIS PATIENTS WITH ILEAL POUCH-ANAL ANASTOMOSIS
IL-33/ST2 AND GUT MICROBIOTA AXIS CAN MODULATE THE INFLAMMATORY PROCESS OF ULCERATIVE COLITIS PATIENTS WITH ILEAL POUCH-ANAL ANASTOMOSIS

Antonio Gasbarrini  et al.

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

Antonio Gasbarrini  et al.

FREE LIGHT CHAINS: NEW POTENTIAL BIOMARKERS FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC FATTY LIVER DISEASE
FREE LIGHT CHAINS: NEW POTENTIAL BIOMARKERS FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC FATTY LIVER DISEASE

Antonio Gasbarrini  et al.

EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN THE INFLAMMATORY PROCESS OF ULCERATIVE COLITIS PATIENTS WITH ILEAL POUCH-ANAL ANASTOMOSIS
EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN THE INFLAMMATORY PROCESS OF ULCERATIVE COLITIS PATIENTS WITH ILEAL POUCH-ANAL ANASTOMOSIS

Antonio Gasbarrini  et al.

SIXTH-LINE ERADICATION THERAPY AGAINST HELICOBACTER PYLORI INFECTION: PRELIMINARY DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
SIXTH-LINE ERADICATION THERAPY AGAINST HELICOBACTER PYLORI INFECTION: PRELIMINARY DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Antonio Gasbarrini  et al.

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonio Gasbarrini  et al.

TOWARDS A PERSONALIZED APPROACH IN ULCERATIVE COLITIS: ROLE OF OCTN1 IN PREDICTING DISEASE SEVERITY AND INDIVIDUAL RESPONSE TO THERAPY
TOWARDS A PERSONALIZED APPROACH IN ULCERATIVE COLITIS: ROLE OF OCTN1 IN PREDICTING DISEASE SEVERITY AND INDIVIDUAL RESPONSE TO THERAPY

Antonio Gasbarrini  et al.

ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonio Gasbarrini  et al.

ENDOSCOPIC ULTRASOUND DIRECT PORTAL PRESSURE MEASUREMENT IS MORE RELIABLE THAN HEPATIC VENOUS PRESSURE GRADIENT MEASUREMENT IN PATIENTS WITH PRE-SINUSOIDAL FORMS OF PORTAL HYPERTENSION
ENDOSCOPIC ULTRASOUND DIRECT PORTAL PRESSURE MEASUREMENT IS MORE RELIABLE THAN HEPATIC VENOUS PRESSURE GRADIENT MEASUREMENT IN PATIENTS WITH PRE-SINUSOIDAL FORMS OF PORTAL HYPERTENSION

Antonio Gasbarrini  et al.

FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS
FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS

Antonio Gasbarrini  et al.

IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING
IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING

Antonio Gasbarrini  et al.

THE POCER INDEX: APPLICATION OF A NOVEL ENDOSCOPIC SCORE IN A REAL-LIFE COHORT OF PATIENTS WITH CROHN'S DISEASE AFTER SURGERY
THE POCER INDEX: APPLICATION OF A NOVEL ENDOSCOPIC SCORE IN A REAL-LIFE COHORT OF PATIENTS WITH CROHN'S DISEASE AFTER SURGERY

Antonio Gasbarrini  et al.

THE SOLUTE CARRIER LC22A4/OCTN1AS A NOVEL IBD DETERMINANT AT THE MICROBE-HOST INTERFACE
THE SOLUTE CARRIER LC22A4/OCTN1AS A NOVEL IBD DETERMINANT AT THE MICROBE-HOST INTERFACE

Antonio Gasbarrini  et al.

Item 1 - 20 / 59
1
2 3